{"count": 12, "results": [{"_id": "34428941", "pmid": 34428941, "title": "Feline comorbidities: The intermingled relationship between chronic kidney disease and hypertension.", "journal": "J Feline Med Surg", "authors": ["Lawson JS", "Jepson RE"], "date": "2021-09-01T00:00:00Z", "doi": "10.1177/1098612X211037872", "meta_date_publication": "2021 Sep", "meta_volume": "23", "meta_issue": "9", "meta_pages": "812-822", "score": 50243.957, "text_hl": "Current guidelines recommend a target systolic blood pressure of <160 mmHg to minimise risk of @<m>DISEASE_Organizing_Pneumonia</m> @DISEASE_MESH:D000092124 @@@TOD@@@. Both @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine besylate@@@ and @CHEMICAL_Telmisartan @CHEMICAL_MESH:D000077333 @@@telmisartan@@@ are effective antihypertensive agents for use in these @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Lawson JS, Jepson RE. Feline comorbidities: The intermingled relationship between chronic kidney disease and hypertension. J Feline Med Surg. 2021 Sep;23(9):812-822. PMID: 34428941", "BibTeX": "@article{34428941, title={Feline comorbidities: The intermingled relationship between chronic kidney disease and hypertension.}, author={Lawson JS and Jepson RE}, journal={J Feline Med Surg}, volume={23}, number={9}, pages={812-822}}"}}, {"_id": "39210934", "pmid": 39210934, "title": "Anti-PL-12 anti-synthetase syndrome manifesting with multiple digital ischemia: Case report & review of the literature.", "journal": "Clin Case Rep", "authors": ["Doumeth SA", "Petrinec E", "Chaudhary H", "Mattar M"], "date": "2024-08-28T00:00:00Z", "doi": "10.1002/ccr3.9408", "meta_date_publication": "2024 Sep", "meta_volume": "12", "meta_issue": "9", "meta_pages": "e9408", "score": 50240.582, "text_hl": "Chest imaging and later lung biopsy were notable for @<m>DISEASE_Organizing_Pneumonia</m> @DISEASE_MESH:D000092124 @@@organizing pneumonia@@@. ", "citations": {"NLM": "Doumeth SA, Petrinec E, Chaudhary H, Mattar M. Anti-PL-12 anti-synthetase syndrome manifesting with multiple digital ischemia: Case report & review of the literature. Clin Case Rep. 2024 Sep;12(9):e9408. PMID: 39210934", "BibTeX": "@article{39210934, title={Anti-PL-12 anti-synthetase syndrome manifesting with multiple digital ischemia: Case report & review of the literature.}, author={Doumeth SA and Petrinec E and Chaudhary H and Mattar M}, journal={Clin Case Rep}, volume={12}, number={9}, pages={e9408}}"}}, {"_id": "8482318", "pmid": 8482318, "title": "Long term effects of amlodipine on organ damage, stroke and life span in stroke prone spontaneously hypertensive rats.", "journal": "Eur J Pharmacol", "authors": ["Suzuki M", "Yamanaka K", "Nabata H", "Tachibana M"], "date": "1993-04-01T00:00:00Z", "doi": "10.1016/0926-6917(93)90060-4", "meta_date_publication": "1993 Apr 1", "meta_volume": "228", "meta_issue": "5-6", "meta_pages": "269-74", "score": 50066.28, "text_hl": "These results indicate that the long term treatment of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ suppresses the incidence of @<m>DISEASE_Organizing_Pneumonia</m> @DISEASE_MESH:D000092124 @@@organ damage@@@ and @DISEASE_Stroke @DISEASE_MESH:D020521 @@@stroke@@@ in SHRSPs and prolongs their life span.", "citations": {"NLM": "Suzuki M, Yamanaka K, Nabata H, Tachibana M. Long term effects of amlodipine on organ damage, stroke and life span in stroke prone spontaneously hypertensive rats. Eur J Pharmacol. 1993 Apr 1;228(5-6):269-74. PMID: 8482318", "BibTeX": "@article{8482318, title={Long term effects of amlodipine on organ damage, stroke and life span in stroke prone spontaneously hypertensive rats.}, author={Suzuki M and Yamanaka K and Nabata H and Tachibana M}, journal={Eur J Pharmacol}, volume={228}, number={5-6}, pages={269-74}}"}}, {"_id": "28595719", "pmid": 28595719, "title": "Effects of carvedilol or amlodipine on target organ damage in L-NAME hypertensive rats: their relationship with blood pressure variability.", "journal": "J Am Soc Hypertens", "authors": ["Del Mauro JS", "Prince PD", "Donato M", "Fernandez Machulsky N", "Morettón MA", "González GE", "Bertera FM", "Carranza A", "Gorzalczany SB", "Chiappetta DA", "Berg G", "Morales C", "Gelpi RJ", "Taira CA", "Höcht C"], "date": "2017-04-01T00:00:00Z", "doi": "10.1016/j.jash.2017.02.007", "meta_date_publication": "2017 Apr", "meta_volume": "11", "meta_issue": "4", "meta_pages": "227-240", "score": 50064.12, "text_hl": "Effects of @CHEMICAL_Carvedilol @CHEMICAL_MESH:D000077261 @@@carvedilol@@@ or @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ on @<m>DISEASE_Organizing_Pneumonia</m> @DISEASE_MESH:D000092124 @@@target organ damage@@@ in @CHEMICAL_NG_Nitroarginine_Methyl_Ester @CHEMICAL_MESH:D019331 @@@L-NAME@@@ @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_10116 @@@rats@@@: their relationship with blood pressure variability.", "citations": {"NLM": "Del Mauro JS, Prince PD, Donato M, Fernandez Machulsky N, Morettón MA, González GE, Bertera FM, Carranza A, Gorzalczany SB, Chiappetta DA, Berg G, Morales C, Gelpi RJ, Taira CA, Höcht C. Effects of carvedilol or amlodipine on target organ damage in L-NAME hypertensive rats: their relationship with blood pressure variability. J Am Soc Hypertens. 2017 Apr;11(4):227-240. PMID: 28595719", "BibTeX": "@article{28595719, title={Effects of carvedilol or amlodipine on target organ damage in L-NAME hypertensive rats: their relationship with blood pressure variability.}, author={Del Mauro JS and Prince PD and Donato M and Fernandez Machulsky N and Morettón MA and González GE and Bertera FM and Carranza A and Gorzalczany SB and Chiappetta DA and Berg G and Morales C and Gelpi RJ and Taira CA and Höcht C}, journal={J Am Soc Hypertens}, volume={11}, number={4}, pages={227-240}}"}}, {"_id": "20859541", "pmid": 20859541, "pmcid": "PMC2941783", "title": "Role of olmesartan in combination therapy in blood pressure control and vascular function", "journal": "Vasc Health Risk Manag", "authors": ["Ferrario CM", "Smith RD"], "date": "2010-09-07T00:00:00Z", "doi": "10.2147/vhrm.s6663", "meta_date_publication": "2010 Sep 7", "meta_volume": "6", "meta_issue": "", "meta_pages": "701-9", "score": 50056.367, "text_hl": "This article summarizes the evidence for the combined use of the AT1 selective receptor antagonist, @CHEMICAL_Olmesartan_Medoxomil @CHEMICAL_MESH:D000068557 @@@olmesartan medoxomil@@@, with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ on blood pressure control and @<m>DISEASE_Organizing_Pneumonia</m> @DISEASE_MESH:D000092124 @@@target organ damage@@@. ", "citations": {"NLM": "Ferrario CM, Smith RD. Role of olmesartan in combination therapy in blood pressure control and vascular function Vasc Health Risk Manag. 2010 Sep 7;6():701-9. PMID: 20859541", "BibTeX": "@article{20859541, title={Role of olmesartan in combination therapy in blood pressure control and vascular function}, author={Ferrario CM and Smith RD}, journal={Vasc Health Risk Manag}, volume={6}, pages={701-9}}"}}, {"_id": "30349279", "pmid": 30349279, "pmcid": "PMC6188174", "title": "Influence of fixed-dose combination perindopril/amlodipine on target organ damage in patients with arterial hypertension with and without ischemic heart disease (results of EPHES trial)", "journal": "Vasc Health Risk Manag", "authors": ["Radchenko GD", "Mushtenko LO", "Sirenko YM"], "date": "2018-10-11T00:00:00Z", "doi": "10.2147/VHRM.S163608", "meta_date_publication": "2018", "meta_volume": "14", "meta_issue": "", "meta_pages": "265-278", "score": 50055.137, "text_hl": "The EPHES trial (Evaluation of influence of fixed dose combination @CHEMICAL_Perindopril @CHEMICAL_MESH:D020913 @@@Perindo-pril@@@/@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ on @<m>DISEASE_Organizing_Pneumonia</m> @DISEASE_MESH:D000092124 @@@target organ damage@@@ in @SPECIES_9606 @@@patients@@@ with arterial HypErtension with or without @DISEASE_Myocardial_Ischemia @DISEASE_MESH:D017202 @@@iSchemic heart disease@@@) compared the dynamics of @<m>DISEASE_Organizing_Pneumonia</m> @DISEASE_MESH:D000092124 @@@target organ damage@@@ (@<m>DISEASE_Organizing_Pneumonia</m> @DISEASE_MESH:D000092124 @@@TOD@@@) in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@ with and without @DISEASE_Myocardial_Ischemia @DISEASE_MESH:D017202 @@@ischemic heart disease@@@ (@DISEASE_Myocardial_Ischemia @DISEASE_MESH:D017202 @@@IHD@@@) treated with the fixed-dose combination (FDC) @CHEMICAL_Perindopril @CHEMICAL_MESH:D020913 @@@perindopril@@@ + @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@.", "citations": {"NLM": "Radchenko GD, Mushtenko LO, Sirenko YM. Influence of fixed-dose combination perindopril/amlodipine on target organ damage in patients with arterial hypertension with and without ischemic heart disease (results of EPHES trial) Vasc Health Risk Manag. 2018;14():265-278. PMID: 30349279", "BibTeX": "@article{30349279, title={Influence of fixed-dose combination perindopril/amlodipine on target organ damage in patients with arterial hypertension with and without ischemic heart disease (results of EPHES trial)}, author={Radchenko GD and Mushtenko LO and Sirenko YM}, journal={Vasc Health Risk Manag}, volume={14}, pages={265-278}}"}}, {"_id": "27779461", "pmid": 27779461, "title": "Differential effects of lercanidipine/enalapril versus amlodipine/enalapril and hydrochlorothiazide/enalapril on target organ damage and sympathetic activation in non-obese essential hypertensive subjects.", "journal": "Curr Med Res Opin", "authors": ["Tsioufis K", "Tsioufis C", "Dimitriadis K", "Mantzouranis E", "Mani I", "Tousoulis D"], "date": "2016-10-01T00:00:00Z", "doi": "10.1080/03007995.2016.1218839", "meta_date_publication": "2016 Oct", "meta_volume": "32", "meta_issue": "sup2", "meta_pages": "35-41", "score": 50053.395, "text_hl": "Differential effects of @CHEMICAL_lercanidipine @CHEMICAL_MESH:C060343 @@@lercanidipine@@@/@CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@ versus @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@/@CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@ and @CHEMICAL_Hydrochlorothiazide @CHEMICAL_MESH:D006852 @@@hydrochlorothiazide@@@/@CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@ on @<m>DISEASE_Organizing_Pneumonia</m> @DISEASE_MESH:D000092124 @@@target organ damage@@@ and sympathetic activation in non-@DISEASE_Obesity @DISEASE_MESH:D009765 @@@obese@@@ @DISEASE_Essential_Hypertension @DISEASE_MESH:D000075222 @@@essential hypertensive@@@ subjects.", "citations": {"NLM": "Tsioufis K, Tsioufis C, Dimitriadis K, Mantzouranis E, Mani I, Tousoulis D. Differential effects of lercanidipine/enalapril versus amlodipine/enalapril and hydrochlorothiazide/enalapril on target organ damage and sympathetic activation in non-obese essential hypertensive subjects. Curr Med Res Opin. 2016 Oct;32(sup2):35-41. PMID: 27779461", "BibTeX": "@article{27779461, title={Differential effects of lercanidipine/enalapril versus amlodipine/enalapril and hydrochlorothiazide/enalapril on target organ damage and sympathetic activation in non-obese essential hypertensive subjects.}, author={Tsioufis K and Tsioufis C and Dimitriadis K and Mantzouranis E and Mani I and Tousoulis D}, journal={Curr Med Res Opin}, volume={32}, number={sup2}, pages={35-41}}"}}, {"_id": "25615941", "pmid": 25615941, "pmcid": "PMC4304790", "title": "Long-Term Treatment of Clonidine, Atenolol, Amlodipine and Dihydrochlorothiazide, but Not Enalapril, Impairs the Sexual Function in Male Spontaneously Hypertensive Rats", "journal": "PLoS One", "authors": ["Lin LL", "Wang D", "Wang W", "Cheng YQ", "Su DF", "Liu AJ"], "date": "2015-01-23T00:00:00Z", "doi": "10.1371/journal.pone.0116155", "meta_date_publication": "2015", "meta_volume": "10", "meta_issue": "1", "meta_pages": "e0116155", "score": 50053.04, "text_hl": "...Effects on @<m>DISEASE_Organizing_Pneumonia</m> @DISEASE_MESH:D000092124 @@@organ damage@@@ in SHR", "citations": {"NLM": "Lin LL, Wang D, Wang W, Cheng YQ, Su DF, Liu AJ. Long-Term Treatment of Clonidine, Atenolol, Amlodipine and Dihydrochlorothiazide, but Not Enalapril, Impairs the Sexual Function in Male Spontaneously Hypertensive Rats PLoS One. 2015;10(1):e0116155. PMID: 25615941", "BibTeX": "@article{25615941, title={Long-Term Treatment of Clonidine, Atenolol, Amlodipine and Dihydrochlorothiazide, but Not Enalapril, Impairs the Sexual Function in Male Spontaneously Hypertensive Rats}, author={Lin LL and Wang D and Wang W and Cheng YQ and Su DF and Liu AJ}, journal={PLoS One}, volume={10}, number={1}, pages={e0116155}}"}}, {"_id": "22747614", "pmid": 22747614, "title": "Aggressive blood pressure-lowering therapy guided by home blood pressure monitoring improves target organ damage in hypertensive patients with type 2 diabetes/prediabetes.", "journal": "J Clin Hypertens (Greenwich)", "authors": ["Eguchi K", "Hoshide S", "Ishikawa S", "Shimada K", "Kario K"], "date": "2012-07-01T00:00:00Z", "doi": "10.1111/j.1751-7176.2012.00648.x", "meta_date_publication": "2012 Jul", "meta_volume": "14", "meta_issue": "7", "meta_pages": "422-8", "score": 50047.516, "text_hl": "The authors tested the hypothesis that an aggressive antihypertensive treatment is beneficial in protecting against @<m>DISEASE_Organizing_Pneumonia</m> @DISEASE_MESH:D000092124 @@@target organ damage@@@ (@<m>DISEASE_Organizing_Pneumonia</m> @DISEASE_MESH:D000092124 @@@TOD@@@) in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@/@DISEASE_Prediabetic_State @DISEASE_MESH:D011236 @@@prediabetes@@@. ", "citations": {"NLM": "Eguchi K, Hoshide S, Ishikawa S, Shimada K, Kario K. Aggressive blood pressure-lowering therapy guided by home blood pressure monitoring improves target organ damage in hypertensive patients with type 2 diabetes/prediabetes. J Clin Hypertens (Greenwich). 2012 Jul;14(7):422-8. PMID: 22747614", "BibTeX": "@article{22747614, title={Aggressive blood pressure-lowering therapy guided by home blood pressure monitoring improves target organ damage in hypertensive patients with type 2 diabetes/prediabetes.}, author={Eguchi K and Hoshide S and Ishikawa S and Shimada K and Kario K}, journal={J Clin Hypertens (Greenwich)}, volume={14}, number={7}, pages={422-8}}"}}, {"_id": "22725706", "pmid": 22725706, "title": "Position of indapamide, a diuretic with vasorelaxant activities, in antihypertensive therapy.", "journal": "Expert Opin Pharmacother", "authors": ["Waeber B", "Rotaru C", "Feihl F"], "date": "2012-07-01T00:00:00Z", "doi": "10.1517/14656566.2012.698611", "meta_date_publication": "2012 Jul", "meta_volume": "13", "meta_issue": "10", "meta_pages": "1515-26", "score": 50042.71, "text_hl": "There is, however, still room for new trials evaluating the combination of this diuretic with other types of antihypertensive drugs, in particular a @CHEMICAL_Calcium @CHEMICAL_MESH:D002118 @@@calcium@@@ antagonist such as @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@. There is also the need to compare the @CHEMICAL_Indapamide @CHEMICAL_MESH:D007190 @@@indapamide@@@-@CHEMICAL_Perindopril @CHEMICAL_MESH:D020913 @@@perindopril@@@ and @CHEMICAL_Indapamide @CHEMICAL_MESH:D007190 @@@indapamide@@@-@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ combinations, in terms of antihypertensive efficacy, tolerability and effects on @<m>DISEASE_Organizing_Pneumonia</m> @DISEASE_MESH:D000092124 @@@target organ damage@@@ and, ideally, on cardiovascular mortality.", "citations": {"NLM": "Waeber B, Rotaru C, Feihl F. Position of indapamide, a diuretic with vasorelaxant activities, in antihypertensive therapy. Expert Opin Pharmacother. 2012 Jul;13(10):1515-26. PMID: 22725706", "BibTeX": "@article{22725706, title={Position of indapamide, a diuretic with vasorelaxant activities, in antihypertensive therapy.}, author={Waeber B and Rotaru C and Feihl F}, journal={Expert Opin Pharmacother}, volume={13}, number={10}, pages={1515-26}}"}}]}